Allogene Therapeutics (ALLO) Shares Issued (2018 - 2026)
Allogene Therapeutics recorded quarterly Shares Issued of $4000.0 in Q1 2026, down 99.55% quarter-over-quarter from $895000.0 in Q4 2025.
Allogene Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $4000.0 for Q1 2026.
- In Q1 2026, Shares Issued changed N/A year-over-year to $4000.0; the TTM figure through Mar 2026 stood at $899000.0 (up 2190.7% YoY), while the FY2025 annual figure was $895000.0, up 10.09% from the prior year.
- Shares Issued came in at $4000.0 for Q1 2026 at Allogene Therapeutics, down from $895000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $1.6 million in Q2 2023 to a low of -$1.1 million in Q3 2022.
- A 5-year average of $382545.5 and a median of $326000.0 in 2023 frame the typical range for Shares Issued.
- Across the five-year window, Shares Issued jumped 227.31% in 2023 and slumped 102.68% in 2024, its largest moves.
- Allogene Therapeutics' Shares Issued stood at -$443000.0 in 2022, then surged by 227.31% to $564000.0 in 2023, then slumped by 107.62% to -$43000.0 in 2024, then soared by 2181.4% to $895000.0 in 2025, then plunged by 99.55% to $4000.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $4000.0, $895000.0, and -$43000.0 for Q1 2026, Q4 2025, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Allogene Therapeutics | 521.43 Mn | 521.43 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 895,000.00 |
| Dec 31, 2025 | 895,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -43,000.00 |
| Mar 31, 2024 | 856,000.00 |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Sep 30, 2023 | 326,000.00 |
| Sep 30, 2023 | 326,000.00 |
| Jun 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Dec 31, 2022 | -443,000.00 |
| Dec 31, 2022 | -443,000.00 |
| Sep 30, 2022 | -1.09 Mn |
| Sep 30, 2022 | -1.09 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 283,000.00 |
| Mar 31, 2022 | 283,000.00 |
| Dec 31, 2021 | -3.62 Mn |
| Dec 31, 2021 | -3.62 Mn |
| Sep 30, 2021 | -3.66 Mn |
| Sep 30, 2021 | -3.66 Mn |
| Jun 30, 2021 | 5.29 Mn |
| Jun 30, 2021 | 5.29 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 592.89 Mn |
| Dec 31, 2020 | 592.89 Mn |
| Sep 30, 2020 | -1.94 Mn |
| Sep 30, 2020 | -1.94 Mn |
| Jun 30, 2020 | 4.48 Mn |
| Jun 30, 2020 | 4.48 Mn |
| Mar 31, 2020 | 303,000.00 |
| Mar 31, 2020 | 303,000.00 |
| Dec 31, 2019 | -703,000.00 |
| Dec 31, 2019 | -703,000.00 |
| Sep 30, 2019 | 467,000.00 |
| Sep 30, 2019 | 467,000.00 |
| Jun 30, 2019 | 236,000.00 |
| Jun 30, 2019 | 236,000.00 |
| Sep 30, 2018 | -3.32 Mn |
| Sep 30, 2018 | -3.32 Mn |
| Jun 30, 2018 | 3.32 Mn |
| Jun 30, 2018 | 3.32 Mn |